Skip to content
Search

Latest Stories

Crest Pharmacy administers over 4,000 jabs from its PureGym site

In a boost to ongoing mass vaccination programme against Covid-19, Crest Pharmacy Group has been successfully running its vaccination drive at PureGym site in Nuneaton town centre of west Midland.

The site has already administered more than 4,000 jabs and will remain a local vaccination centre until June, meaning PureGym won’t be able to open the location as a gym before then.


The gym bound vaccination centre has proved popular among patients as it is accessible and spacious, having air filtration and adequate parking, the pharmacy said elaborating its efforts to boost vaccination drive in the locality.

Teams of volunteers from the Royal Voluntary Service are also helping the smooth running of the site by performing key marshalling duties.

Carl Rose, commercial manager at Crest Pharmacy Group, said: “We are proud to be part of the national vaccination project – it has been professionally satisfying to help patients directly. The project also demonstrates the importance and value of community pharmacy in delivering nationwide healthcare services on behalf of the NHS and the UK government.”

A spokesperson for PureGym also commented: “PureGym is delighted its Nuneaton gym is operating as a vaccine hub until mid-June, and it is fantastic news that so many jabs have already been administered. We at PureGym alongside Crest Pharmacy Group, are thrilled to be playing our part in England’s COVID-19 vaccine roll-out.”

Earlier, the national gym chain PureGym offered their venues to the NHS for use as vaccination sites in December when the company saw that their gyms were lying empty during the multiple lockdowns and realised that the sites could be harnessed for the national Covid-19 vaccination effort.

More For You

Aspire Pharma acquisition boosts access to essential medicines for NHS patients in the UK

The acquisition is expected to further drive the company’s growth.

gettyimages

Aspire acquires UK distribution rights from Tetris

Aspire Pharma Limited, one of the UK’s fastest-growing specialty niche generics companies, has announced the acquisition of UK distribution rights to a number of products from Tetris Pharma, a subsidiary of Arecor Therapeutics.

These include products used in the treatment of bacterial infections—such as injectable and intravenous antibiotics—as well as a medicine indicated for acute myocardial infarction (MI) and deep vein thrombosis (DVT).

Keep ReadingShow less
GP surgery upgrades for annual appointments

The surgeries will have additional space to “see more patients, boost productivity and improve patient care”

Pic credit: iStock

GP surgery upgrades to create 8.3 million more annual appointments

Over 1,000 GP surgeries will have their premises modernised to meet the needs of a further 8.3 million appointments each year, the government has announced.

Backed by a cash injection of over £102 million, the surgeries will have additional space to “see more patients, boost productivity and improve patient care”.

Keep ReadingShow less
Wales boosts funding for pharmacy-led UTI and sore throat test services

The sore throat test (STTT) and treat service will be widely available

Pic credit: istock

Welsh pharmacies receive funding boost for clinical services

Two key clinical services will be available in 99 per cent of community pharmacies across Wales after a boost in funding.

The sore throat test (STTT) and treat service and the urinary tract infection (UTI) service have both benefitted from contractual negotiations between the Welsh Government and Community Pharmacy Wales (CPW).

Keep ReadingShow less
Paul Bennett
Paul Bennett, CEO, Royal Pharmaceutical Society
Paul Bennett, CEO, Royal Pharmaceutical Society

Pharmacists need to take advantage of independent prescribing pathways, says Bennett

Independent prescribing will be a “significant point” in the history of community pharmacy, according to Royal Pharmaceutical Society chief executive Paul Bennett.

Last month, the RPS announced the launch of a comprehensive new prescribing development programme to support pharmacists across all stages of their prescribing careers.

Keep ReadingShow less